| Literature DB >> 31821096 |
Rupesh Agrawal1,2,3, Aniruddha Agarwal4, Douglas A Jabs5,6, Aera Kee1, Ilaria Testi2, Sarakshi Mahajan7, Peter J McCluskey8, Amod Gupta4, Alan Palestine9, Alastair Denniston10, Alay Banker11, Alessandro Invernizzi12, Alex Fonollosa13, Aman Sharma14, Amitabh Kumar15, Andre Curi16, Annabelle Okada17, Ariel Schlaen18, Arnd Heiligenhaus19, Atul Kumar20, Avinash Gurbaxani2, Bahram Bodaghi21, Bulbul Islam Shah22, Careen Lowder23, Christoph Tappeiner24, Cristina Muccioli25, Daniel Vitor Vasconcelos-Santos26, Debra Goldstein27, Digambar Behra28, Dipankar Das29, Dorine Makhoul30, Edoardo Baglivo31, Ekaterina Denisova32, Elisabetta Miserocchi33, Ester Carreno34, Fatma Asyari35, Francesco Pichi36, H Nida Sen37, Harvey Uy38, Heloisa Nascimento25, Ilknur Tugal-Tutkun39, J Fernando Arevalo40, Janet Davis41, Jennifer Thorne42, Joyce Hisae Yamamoto43, Justine Smith44, Justus G Garweg45, Jyotirmay Biswas46, Kalpana Babu47, Kanika Aggarwal4, Luca Cimino48, Lucia Kuffova49, Mamta Agarwal46, Manfred Zierhut50, Manisha Agarwal51, Marc De Smet52, Maria Sofia Tognon53, Marie-Helene Errera54, Marion Munk24, Mark Westcott2, Masoud Soheilian55, Massimo Accorinti56, Moncef Khairallah57, Myhanh Nguyen58, Onn Minn Kon59, Padmamalini Mahendradas60, Peizeng Yang61, Piergiorgio Neri36, Pinar Ozdal62, Radgonde Amer63, Richard Lee2, Rina La Distia Nora35, Romi Chhabra64, Rubens Belfort25, Salil Mehta65, Samir Shoughy66, Saurabh Luthra67, Shelina Oli Mohamed68, Soon-Phaik Chee69, Soumyava Basu70, Stephen Teoh71, Sudha Ganesh46, Talin Barisani-Asenbauer72, Yan Guex-Crosier73, Yılmaz Ozyazgan39, Yonca Akova74, Zohar Habot-Wilner75, John Kempen76, Quan Dong Nguyen7, Carlos Pavesio2, Vishali Gupta4.
Abstract
Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB).Entities:
Keywords: Antitubercular therapy; Ocular tuberculosis; remission; tubercular uveitis; tuberculous; uveitis
Year: 2019 PMID: 31821096 DOI: 10.1080/09273948.2019.1653933
Source DB: PubMed Journal: Ocul Immunol Inflamm ISSN: 0927-3948 Impact factor: 3.728